天赐材料(002709) - 2026年3月10日投资者关系活动记录表

Financial Performance - In 2025, the company achieved a revenue of CNY 16.65 billion, representing a year-on-year growth of 33% [1] - The net profit attributable to shareholders was CNY 1.362 billion, with a significant increase of 181.43% [1] - The net profit after deducting non-recurring gains and losses was CNY 1.36 billion, up by 256.32% [1] - Basic earnings per share reached CNY 0.71 [1] Product Sales and Market Trends - The sales volume of the core product, electrolyte, exceeded 720,000 tons, marking a year-on-year growth of approximately 44% [1] - The annual sales of daily chemical materials surpassed 120,000 tons, reflecting a 10% increase compared to the previous year [1] - The overall revenue from the daily chemical materials business grew by 10.69% [1] Production Capacity and Resource Management - The company plans to add 35,000 tons of new production capacity for lithium hexafluorophosphate, with production expected to commence in the second half of 2026 [2] - The company is actively diversifying its lithium resource layout, including mining and recycling operations, to optimize raw material costs [2] - The production capacity for iron phosphate is currently at 300,000 tons, with efforts to improve operational efficiency and reduce costs [2] New Material Development - The current addition ratio of LiFSI in electrolytes is approximately 2%-2.5%, with expectations for an increase due to rising demand for high-performance formulations [3] - The company is in the kilogram-level trial production phase for sulfide solid electrolytes, with a pilot production line expected to be operational in Q3 2026 [3] - The company has established production capabilities for sodium-ion electrolytes and will gradually increase production based on market demand [3] International Expansion and IPO Progress - Overseas projects in Morocco and the USA have commenced, with completion expected between late 2027 and mid-2028 [4] - The company submitted its Hong Kong IPO application in September 2025 and is currently awaiting approval from the China Securities Regulatory Commission, with a typical review period of 6-9 months [5]